4th Quarter - Report
K&L GATES, LLP for PEAR THERAPEUTICS, INC.
Firm
Client
Income
$20,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
H.R.7051, S.3791, Access to Prescription Digital Therapeutics Act of 2022; Federal policy related to prescription digital therapeutics. S.5238, Medicaid and CHIP Access to Prescription Digital Therapeutics Act; Federal policy related to prescription digital therapeutics.
| Lobbyist | Covered position, as disclosed |
|---|---|
| AMY CARNEVALE | — |
| MICHAEL WILLIAM EVANS New | Democratic Chief Counsel and Deputy Staff Director, U.S. Senate Committee on Finance, |
| PAMELA GARVIE | — |
| SCOTT J. GELBMAN New | Staff Assistant/Legislative Correspondent/Legislative Assistant, Senator Chuck Schumer |
| BART GORDON | — |
| SCOTT NELSON | — |
| DENNIS POTTER | — |
| SARAH SWANSON | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.